Animal models are established, important tools for preclinical safety and efficacy testing. Companies are advancing more “humanized” models to better reflect human responses, while at the same time ...
ABION, a precision oncology therapeutics developer, announced its next-generation immuno-oncology candidate ABN202 will be ...
Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, ...
By incorporating these advanced models into preclinical packages for the FDA, researchers can provide a much stronger proof ...
HKeyBio, a global leading CRO specializing in preclinical and translational research for autoimmune and allergic diseases, ...
The power of CRISPR became definitively clear when the first CRISPR-based gene therapy, Casgevy (exa-cel), won regulatory approvals for the treatment of sickle cell disease. But CRISPR’s applications ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Seismic Therapeutic, Inc., the machine learning immunology company, today announced the presentation of preclinical data for its immunoglobulin E (IgE) protease, ...
Zymeworks presents six posters at AACR highlighting advancements in antibody-drug conjugates and T cell engagers, including ZW209's promise in lung cancer. Zymeworks Inc. announced the presentation of ...
Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody ...
KAWASAKI, Japan--(BUSINESS WIRE)--PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587) today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results